Against Chikungunya Virus and Neonatal Infection

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2027

Conditions
Chikungunya Virus InfectionNeonatalTransfusionEncephalopathy
Interventions
BIOLOGICAL

plasma transfusion : PC-CHIK-V

plasma transfusion , from donation from an individual who has declared a Chikungunya infection for less than 6 months , to a newborn, whose mother has a peripartum chikungunya infection

Trial Locations (1)

97410

CHU La Réunion, Saint-Pierre

All Listed Sponsors
lead

Centre Hospitalier Universitaire de la Réunion

OTHER

NCT07190560 - Against Chikungunya Virus and Neonatal Infection | Biotech Hunter | Biotech Hunter